Novel interventions for the treatment of triglycerides, cholesterol and bile acids diseases with human CAR ligands 19-14497S 2019-2021
Horizon 2020 - Metabolic effects of Endocrine Disrupting Chemicals: novel testing methods and adverse outcome Pathways (EDCMET) 2018-2023
Horizon 2020 COST action - The European Network on Understanding Gastrointestinal Absorption-related Processes (UNGAP)